Despite Medicaid pressures, Elevance reports strong Q1 earnings

Elevance Health Inc. (NYSE: ELV) reported strong first quarter 2025 earnings Tuesday, with operating revenue rising 15.4% year-over-year to $48.8 billion. The Indianapolis-based healthcare giant also posted a 4.1% gain in adjusted operating income to $3.3 billion, despite margin pressure in its Medicaid segment.

Adjusted diluted earnings per share came in at $11.97 for the quarter, and the company reaffirmed its full-year 2025 guidance range of $34.15 to $34.85.

CEO Gail Boudreaux said Elevance continued to make headway on its strategy to reimagine the healthcare experience through technology and whole-health integration. “Across our businesses, we’re staying focused on what we can control, delivering operational results, engaging proactively with partners, and advancing our long-term strategy,” Boudreaux said in a Tuesday morning call with analysts.

Carelon Delivers Major Growth, Offsetting Medicaid Drag

Elevance’s Carelon segment was a standout in the quarter, with operating revenue jumping 38% to $16.7 billion, driven by acquisitions in home health and pharmacy services and strong growth at CarelonRx. Adjusted operating gain rose to $1.1 billion from $0.9 billion a year ago, reflecting both scale and improved performance in Carelon Health.

By contrast, the Health Benefits segment—which includes Medicare, Medicaid, and commercial plans—saw operating gain fall slightly to $2.2 billion from $2.3 billion. A higher medical cost trend in Medicaid impacted results, though that was partially offset by growth in Medicare Advantage and Individual ACA enrollment.

“We remain confident in the long-term outlook for Medicare Advantage,” Boudreaux said. “Stronger retention not only improves member satisfaction, it’s associated with better care coordination, fewer inpatient stays, and lower overall Medicare spending.”

Quarterly Snapshot:

– Operating Revenue: $48.8 billion (up 15.4% year-over-year)
– Adjusted Operating Gain: $3.3 billion (up 4.1%)
– Adjusted Operating Margin: 6.7% (down from 7.4% in 1Q 2024)
– Adjusted Diluted EPS: $11.97
– FY 2025 EPS Guidance: Reaffirmed at $34.15–$34.85
– Capital Returned to Shareholders: $1.3 billion in Q1 2025
-Stock Price Movement: Stock is down 21% for the year, to $416 per share, down 2% in mid-day trading Tuesday

Management Perspective:

Elevance’s leadership emphasized the value of diversification across its enterprise. “Through Carelon and our broader enterprise, we’re delivering on our strategy to be a lifetime trusted health partner,” Boudreaux said, underscoring efforts to control costs and improve outcomes via digital and value-based care.

The company also noted improvements in expense ratios, with the adjusted operating expense ratio improving 60 basis points year-over-year to 10.7%. This was largely due to revenue leverage and continued cost discipline.

By The Numbers:

– Cash Flow from Operations: $1.0 billion (down $1.0 billion YOY due to timing)
– Share Repurchases: 2.2 million shares for $880 million
– Dividend Paid: $1.71/share ($386 million distributed)
– Total Membership: 45.8 million (up 99,000 since year-end 2024)
– Benefit Expense Ratio: 86.4% (up 80 bps YOY)
– Days in Claims Payable: 44.0 days (up 0.5 days sequentially)

Health Benefits Picture:

– Revenue: $41.4 billion (up 11%)
– Adjusted Operating Gain: $2.2 billion (down slightly)
– Medicaid Drag: Medical cost pressures weighed on segment margin (5.4%, down from 6.2%)

Carelon Picture:

– Revenue: $16.7 billion (up 38%)
– Adjusted Operating Gain: $1.1 billion (up 22%)
– Growth Drivers: Home health, CarelonRx, value-based service expansion

Dividend Declared:

Elevance declared a second quarter dividend of $1.71 per share, payable June 25, 2025, to shareholders of record as of June 10.

© Entire contents copyright 2025 by InsuranceNewsNet.com Inc. All rights reserved. No part of this article may be reprinted without the expressed written consent from InsuranceNewsNet.com.

The post Despite Medicaid pressures, Elevance reports strong Q1 earnings appeared first on Insurance News | InsuranceNewsNet.